Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Refractory B-cell Non Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01965119
What this trial is testing

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPrimary Mediastinal Large B-cell Lymphoma
Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT05459571
What this trial is testing

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Large B-cell Lymphoma
Kite, A Gilead Company 35
Testing effectiveness (Phase 2)Study completedNCT00006252
What this trial is testing

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Cancer and Leukemia Group B 47
Testing effectiveness (Phase 2)Study completedNCT00005592
What this trial is testing

Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 23
Testing effectiveness (Phase 2)Study completedNCT00119392
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+14 more
Fred Hutchinson Cancer Center 42
Early research (Phase 1)Study completedNCT00002909
What this trial is testing

Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01682044
What this trial is testing

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Grade 3 Follicular Lymphoma+30 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT01371630
What this trial is testing

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6 more
M.D. Anderson Cancer Center 276
Testing effectiveness (Phase 2)Study completedNCT02998476
What this trial is testing

Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Who this might be right for
Lymphoma
Incyte Corporation 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05578976
What this trial is testing

Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Genmab 900
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Not applicableEnded earlyNCT00005786
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Not applicableUnknownNCT05269914
What this trial is testing

Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
The Affiliated Hospital of Qingdao University 10
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Very early researchStudy completedNCT01719250
What this trial is testing

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma+2 more
Mayo Clinic 7
Next Page